APA (7th ed.) Citation

Lin, Y., Wang, Y., Wu, C., Chang, Y., Chen, C., & Song, Z. (2025). Risk of Herpes Zoster With Janus Kinase Inhibitors Across Disease Indications: A Systematic Review and Network Meta‐Analysis. Dermatologic Therapy, 2025, 1. https://doi.org/10.1155/dth/2928433

Chicago Style (17th ed.) Citation

Lin, Yu-Hsiang, Yu-Ching Wang, Chen-Yi Wu, Yun-Ting Chang, Chih-Chiang Chen, and Zhiqiang Song. "Risk of Herpes Zoster With Janus Kinase Inhibitors Across Disease Indications: A Systematic Review and Network Meta‐Analysis." Dermatologic Therapy 2025 (2025): 1. https://doi.org/10.1155/dth/2928433.

MLA (9th ed.) Citation

Lin, Yu-Hsiang, et al. "Risk of Herpes Zoster With Janus Kinase Inhibitors Across Disease Indications: A Systematic Review and Network Meta‐Analysis." Dermatologic Therapy, vol. 2025, 2025, p. 1, https://doi.org/10.1155/dth/2928433.